PERIMETER MEDICAL IMAGING AI (PINK.CA) Stock Fundamental Analysis
Canada - TSX Venture Exchange - TSX-V:PINK - CA71385D1078 - Common Stock
0.18 CAD
0 (0%)
We assign a fundamental rating of 2 out of 10 to PINK. PINK was compared to 15 industry peers in the Health Care Equipment & Supplies industry. PINK has a bad profitability rating. Also its financial health evaluation is rather negative. PINK is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PINK has reported negative net income.
In the past year PINK has reported a negative cash flow from operations.
PINK had negative earnings in each of the past 5 years.
PINK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -235.45%, PINK is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
With a Return On Equity value of -361.48%, PINK perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -235.45% | ||
| ROE | -361.48% | ||
| ROIC | N/A |
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of PINK (62.17%) is better than 73.33% of its industry peers.
PINK's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for PINK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.17% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
2. Health
2.1 Basic Checks
PINK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PINK has been increased compared to 1 year ago.
PINK has more shares outstanding than it did 5 years ago.
PINK has a worse debt/assets ratio than last year.
2.2 Solvency
PINK has an Altman-Z score of -23.11. This is a bad value and indicates that PINK is not financially healthy and even has some risk of bankruptcy.
PINK has a Altman-Z score of -23.11. This is in the lower half of the industry: PINK underperforms 60.00% of its industry peers.
PINK has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
PINK has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. PINK outperforms 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -23.11 |
ROIC/WACCN/A
WACC7.83%
2.3 Liquidity
A Current Ratio of 1.61 indicates that PINK should not have too much problems paying its short term obligations.
PINK has a Current ratio of 1.61. This is in the better half of the industry: PINK outperforms 80.00% of its industry peers.
PINK has a Quick Ratio of 1.55. This is a normal value and indicates that PINK is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of PINK (1.55) is better than 93.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.55 |
3. Growth
3.1 Past
PINK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -13.70%.
Looking at the last year, PINK shows a very strong growth in Revenue. The Revenue has grown by 209.29%.
Measured over the past years, PINK shows a very strong growth in Revenue. The Revenue has been growing by 354.72% on average per year.
EPS 1Y (TTM)-13.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.12%
Revenue 1Y (TTM)209.29%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%107.72%
3.2 Future
The Earnings Per Share is expected to grow by 19.59% on average over the next years. This is quite good.
The Revenue is expected to grow by 119.37% on average over the next years. This is a very strong growth
EPS Next Y21.56%
EPS Next 2Y20.02%
EPS Next 3Y18.41%
EPS Next 5Y19.59%
Revenue Next Year269.92%
Revenue Next 2Y209.51%
Revenue Next 3Y171.19%
Revenue Next 5Y119.37%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
PINK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PINK. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PINK's earnings are expected to grow with 18.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.02%
EPS Next 3Y18.41%
5. Dividend
5.1 Amount
No dividends for PINK!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:PINK (11/21/2025, 7:00:00 PM)
0.18
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners24.49%
Inst Owner ChangeN/A
Ins Owners13.68%
Ins Owner ChangeN/A
Market Cap21.38M
Revenue(TTM)1.56M
Net Income(TTM)-16.29M
Analysts80
Price Target1.77 (883.33%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.65%
Min EPS beat(2)-18.81%
Max EPS beat(2)22.11%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)64.15%
Min Revenue beat(2)-32.1%
Max Revenue beat(2)160.4%
Revenue beat(4)3
Avg Revenue beat(4)33.24%
Min Revenue beat(4)-32.1%
Max Revenue beat(4)160.4%
Revenue beat(8)4
Avg Revenue beat(8)4.28%
Revenue beat(12)6
Avg Revenue beat(12)-0.89%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)26.09%
EPS NY rev (1m)0%
EPS NY rev (3m)30.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)12.28%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.39%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 9.76 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.37 | ||
| P/tB | 3.37 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.2
Fwd EYN/A
FCF(TTM)-0.19
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS0.02
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -235.45% | ||
| ROE | -361.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 62.17% | ||
| FCFM | N/A |
ROA(3y)-63.49%
ROA(5y)-88.85%
ROE(3y)-86.41%
ROE(5y)-118.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.47%
GM growth 5YN/A
F-Score3
Asset Turnover0.23
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 235.94% | ||
| Cap/Sales | 123.45% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.55 | ||
| Altman-Z | -23.11 |
F-Score3
WACC7.83%
ROIC/WACCN/A
Cap/Depr(3y)208.17%
Cap/Depr(5y)571.74%
Cap/Sales(3y)624.9%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%19.12%
EPS Next Y21.56%
EPS Next 2Y20.02%
EPS Next 3Y18.41%
EPS Next 5Y19.59%
Revenue 1Y (TTM)209.29%
Revenue growth 3Y354.72%
Revenue growth 5YN/A
Sales Q2Q%107.72%
Revenue Next Year269.92%
Revenue Next 2Y209.51%
Revenue Next 3Y171.19%
Revenue Next 5Y119.37%
EBIT growth 1Y11.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year8.29%
EBIT Next 3Y15.32%
EBIT Next 5Y23.3%
FCF growth 1Y-50.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.5%
OCF growth 3YN/A
OCF growth 5YN/A
PERIMETER MEDICAL IMAGING AI / PINK.CA FAQ
What is the ChartMill fundamental rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to PINK.CA.
What is the valuation status of PERIMETER MEDICAL IMAGING AI (PINK.CA) stock?
ChartMill assigns a valuation rating of 0 / 10 to PERIMETER MEDICAL IMAGING AI (PINK.CA). This can be considered as Overvalued.
Can you provide the profitability details for PERIMETER MEDICAL IMAGING AI?
PERIMETER MEDICAL IMAGING AI (PINK.CA) has a profitability rating of 1 / 10.
Can you provide the financial health for PINK stock?
The financial health rating of PERIMETER MEDICAL IMAGING AI (PINK.CA) is 3 / 10.